High-affinity low-molecular weight ligands to CA IX have been reported (Supuran, 2008) and it will be interesting to compare their in vivo tumour targeting properties with those of the human antibodies A3 and CC7 with a molecular weight of 76 kDa. The gene discussed is CA9; the disease is neoplasm.